- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Rectal Cancer - Dr. Poulami Basu - Video
Overview
In this video, Dr Poulami Basu, Medical Oncologist at Netaji Subhas Chandra Bose Cancer Hospital, Pancha Sayar, Kolkata, presents a real-world oncology case focused on managing chemotherapy-induced anemia (CIA) in a patient with advanced rectal cancer.
The case involves a 55-year-old female homemaker, diagnosed with Stage IV rectal carcinoma, with no significant family history of cancer. While receiving palliative chemotherapy, the patient developed symptomatic anemia—posing challenges to treatment continuation and overall well-being.
Dr. Basu discusses how timely administration of darbepoetin alfa played a pivotal role in improving her hemoglobin levels, maintaining chemotherapy schedule, and significantly enhancing her quality of life. This case underscores the importance of proactive anemia management in metastatic cancer care and highlights the real-world benefits of darbepoetin alfa in supporting patient outcomes.